This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Anticoagulants Industry

DVT Prevention in Surgery (includes corresponding

Graph/Chart) III-4

Payers Keen on New Therapies III-4

Pradaxa's Initial Performance Commendable, Conventional AVK

Products Still Dominate III-4

US Heparin Market III-5

Hinging on Market Opportunities III-5

Generics - Threatening Branded Anticoagulants III-5

List of Patent Protected Anticoagulants in the US III-6

Generic Competition Threatens Sanofi's Lovenox III-6

Table 26: Leading Players in the US Enoxaparin Sodium

Market (2011): Percentage Breakdown of Sales for Sandoz and

Sanofi (includes corresponding Graph/Chart) III-6

 

Table 27: US Enoxaparin Sodium Market by Sector (2011):

Percentage Breakdown of Sales for Institutional and Retail

Sectors (includes corresponding Graph/Chart) III-6

Ignorance - A Major Hindrance III-7

Future Challenges and Growth Drivers III-7

US Emerging Anticoagulant Market III-7

Product Introductions/Approvals III-8

Recent Industry Activity III-8

Focus on Select Players III-10

B.Market Analytics III-12

Table 28: US Recent Past, Current & Future Analysis for

Anticoagulants by Product Segment - Oral Anticoagulants and

Injectable Anticoagulants (Unfractionated Heparin and Low

Molecular Weight Heparin) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2010

through 2018 (includes corresponding Graph/Chart) III-12

 

Table 29: US Historic Review for Anticoagulants by Product

Segment - Oral Anticoagulants and Injectable Anticoagulants

(Unfractionated Heparin and Low Molecular Weight Heparin)

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-13

 

Table 30: US 15-Year Perspective for Anticoagulants by

Product Segment - Percentage Breakdown of Dollar Sales for

Oral Anticoagulants and Injectable Anticoagulants

(Unfractionated Heparin and Low Molecular Weight Heparin)

Markets for the Years 2004, 2011 & 2018 (includes

corresponding Graph/Chart) III-14

 

2. JAPAN III-15

A.Market Analysis III-15

Outlook III-15

Anticoagulants Market in Japan III-15

Rising Incidence of Pulmonary Thromboembolism III-15

Product Introductions/Approvals III-15

Recent Industry Activity III-16

Focus on Select Players III-16

9 of 15

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs